(0458–0497) Vasculitis – Non-ANCA-Associated and Related Disorders Poster I: Giant Cell Arteritis

Poster abstract session.

Presentations:

• 1:00 PM – 3:00 PM Eastern Time

  Predictive Models for Thromboembolic Events in Giant Cell Arteritis: A US Veterans Health Administration Population-Based Study
  

  Abstract Poster Presenter: Despoina Michailidou, MD – University of Washington
• 1:00 PM – 3:00 PM Eastern Time

  The Use of Intravenous Methylprednisolone in Patients with Giant Cell Arteritis: A Population-Based Study
  

  Abstract Poster Presenter: Hampus Henningson, MSc – Lund University
• 1:00 PM – 3:00 PM Eastern Time

  Baseline Glucocorticoid Toxicity in the Treatment of Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial
  

  Abstract Poster Presenter: Naomi Patel, MD – Massachusetts General Hospital
• 1:00 PM – 3:00 PM Eastern Time

  The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A1c During the Treatment of Giant Cell Arteritis
  

  Abstract Poster Presenter: Naomi Patel, MD – Massachusetts General Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Increasing Incidence of Large Artery Manifestations in Patients with Giant Cell Arteritis, a Population-based Cohort over 70 Years
  

  Abstract Poster Presenter: Mohanad Elfishawi, MS, MBBCH – Mayo Clinic
• 1:00 PM – 3:00 PM Eastern Time

  Utilization of a Giant Cell Arteritis Fast-Track Program Independent of Ultrasound at a Single Center
  

  Abstract Poster Presenter: Christina Costeas, MD – Columbia University Irving Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  JAKINIB in Refractory Giant Cell Arteritis. National Multicenter Study of 15 Cases and Literature Review
  

  Abstract Poster Presenter: Diana Prieto-Peña, PhD – Hospital Universitario Marqués de Valdecilla
• 1:00 PM – 3:00 PM Eastern Time

  Tocilizumab in Large-Vessel Giant Cell Arteritis and Takayasu Arteritis: Multicentric Observational Comparative Study
  

  Abstract Poster Presenter: Diana Prieto-Peña, PhD – Hospital Universitario Marqués de Valdecilla
• 1:00 PM – 3:00 PM Eastern Time

  Assessment of Probability Scores to Predict Giant Cell Arteritis
  

  Abstract Poster Presenter: Chadi Sargi, MD – Université de Montréal
• 1:00 PM – 3:00 PM Eastern Time

  All-Cause and Cause-Specific Mortality in Giant Cell Arteritis, a Population-based Study
  

  Abstract Poster Presenter: Jacob Sode, MD, PhD – Skåne University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Ultrasound Wall Thickness in the Differential Diagnosis of Atherosclerosis and Large Vessel Giant Cell Arteritis
  

  Abstract Poster Presenter: Eugenio De Miguel, MD, PhD – Hospital Universitario La Paz
• 1:00 PM – 3:00 PM Eastern Time

  Factors Associated with Corticosteroid Dosing in the Management of Giant Cell Arteritis
  

  Abstract Poster Presenter: Loukas Kakoullis, MD, MPH – Mount Auburn Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Long-term Efficacy of Tocilizumab Monotherapy After Ultra-short Glucocorticoid Administration to Treat Giant Cell Arteritis – One Year Follow-up of the GUSTO Trial
  

  Abstract Poster Presenter: Lisa Christ, MD – Inselspital, University Bern, Switzerland
• 1:00 PM – 3:00 PM Eastern Time

  Serum Proteomics in Giant Cell Arteritis: Findings of the Giant Cell Arteritis Treatment with Ultra-short Glucocorticoids and Tocilizumab Trial (The GUSTO Trial)
  

  Abstract Poster Presenter: Lisa Christ, MD – Inselspital, University Bern, Switzerland
• 1:00 PM – 3:00 PM Eastern Time

  The Common Carotid Artery in the Ultrasound Evaluation of Giant Cell Arteritis
  

  Abstract Poster Presenter: Charles Oshinsky, MD, RhMSUS – Arthritis & Rheumatism Associates
• 1:00 PM – 3:00 PM Eastern Time

  Comprehensive Assessment of Cranial and Orbital Vasculature on MRI in Patients with Giant Cell Arteritis
  

  Abstract Poster Presenter: Rennie Rhee, MD, MS – University of Pennsylvania
• 1:00 PM – 3:00 PM Eastern Time

  Utility of Optimization of Tocilizumab Therapy in Giant Cell Arteritis: A Multicenter Study of 471 Patients
  

  Abstract Poster Presenter: Fabricio Benavides, MD РHospital Universitario Marqu̩s de Valdecilla
• 1:00 PM – 3:00 PM Eastern Time

  Whole-country and Regional Incidences of Giant Cell Arteritis in French Continental and Overseas Territories: A Nationwide Database Analysis
  

  Abstract Poster Presenter: Hubert de Boysson, MD, PhD – Caen university Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Permanent Vision Loss in Giant Cell Arteritis: Why the Incidence Remains High
  

  Abstract Poster Presenter: Thomas Daikeler, MD – university hospital
• 1:00 PM – 3:00 PM Eastern Time

  Can Beta-blockers Prevent Aortic Dilation in Patients with Giant Cell Arteritis and Large Vessel Vasculitis?
  

  Abstract Poster Presenter: Hubert de Boysson, MD, PhD – Caen university Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Sonographic Prevalence of Subclinical GCA in Newly Diagnosed PMR
  

  Abstract Poster Presenter: Colm Kirby, MD – Tallaght University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  A Prospective Study Evaluating the Utility of Ultrasound in Monitoring Newly-Diagnosed GCA
  

  Abstract Poster Presenter: Colm Kirby, MD – Tallaght University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Treatment of Giant Cell Arteritis Patients with Ultra-short Glucocorticoids and Tocilizumab: Role of Imaging in a Prospective Study
  

  Abstract Poster Presenter: Chiara Marvisi, MD – University of Modena e Reggio Emilia and NIAMS, NIH
• 1:00 PM – 3:00 PM Eastern Time

  Glucocorticoid-related Adverse Events in Giant Cell Arteritis: Application of the Glucocorticoid Toxicity Index in a Monocentric Cohort of 140 Patients
  

  Abstract Poster Presenter: Francesca Regola, MD – Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia
• 1:00 PM – 3:00 PM Eastern Time

  Role of miR-146a and miR-146b in Giant Cell Arteritis
  

  Abstract Poster Presenter: Stefania Croci, PhD, BSc – Azienda Unità Sanitaria Locale-IRCCS
• 1:00 PM – 3:00 PM Eastern Time

  Giant Cell Arteritis: Physical Examination of the Superficial Temporal Arteries Can Predict Temporal Artery Biopsy Result
  

  Abstract Poster Presenter: Giuseppe Antonio Germano, MD – Rheumatology Unit- Arcispedale Santa Maria Nuova Reggio Emilia-Italy
• 1:00 PM – 3:00 PM Eastern Time

  Epidemiology and Predictors of Relapse in Giant Cell Arteritis: A Systematic Review and Meta-analysis
  

  Abstract Poster Presenter: Lien Moreel, MD – UZ Leuven
• 1:00 PM – 3:00 PM Eastern Time

  Assessing the Effectiveness of Tocilizumab in Newly Diagnosed Giant Cell Arteritis versus Refractory/recurrent Giant Cell Arteritis in Clinical Practice
  

  Abstract Poster Presenter: Julio Sanchez Martin, MD – Hospital Universitario Marqués de Valdecilla
• 1:00 PM – 3:00 PM Eastern Time

  Gene Expression Profile of Temporal Artery Tissue and Whole Blood in Giant Cell Arteritis
  

  Abstract Poster Presenter: Marcia Friedman, MD – Alpine Immune Sciences
• 1:00 PM – 3:00 PM Eastern Time

  A Systematic Literature Review to Generate Descriptors for the Development of New Response Criteria in Giant Cell Arteritis
  

  Abstract Poster Presenter: Catalina Sanchez Alvarez, MD – University of Florida
• 1:00 PM – 3:00 PM Eastern Time

  Discrepancies in Temporal Artery Biopsy Positivity Rate Among White and Black Patients Suspected of Having Giant Cell Arteritis: Experience from a Tertiary Academic Medical Center
  

  Abstract Poster Presenter: Raj Vachhani, MD – UAB
• 1:00 PM – 3:00 PM Eastern Time

  Giant Cell Arteritis Phenotypes and Diagnosis of Aortitis Among 1852 Patients Before and After 2016 Across 10 French Referral Centers
  

  Abstract Poster Presenter: Laurent Sailler, MD, PhD – CHU Toulouse
• 1:00 PM – 3:00 PM Eastern Time

  Analysis of Emergency Department Visits by Patients with Giant Cell Arteritis: A National Population-based Study
  

  Abstract Poster Presenter: Amy Trang, MD – Rush University Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Markers of Neutrophil Activation in Patients with ANCA-associated Vasculitis and Large-vessel Vasculitis
  

  Abstract Poster Presenter: Despoina Michailidou, MD – University of Washington
• 1:00 PM – 3:00 PM Eastern Time

  Longitudinal Tends of Hospitalizations for Giant Cell Arteritis: A 21-year Longitudinal National Population-based Study
  

  Abstract Poster Presenter: Amy Trang, MD – Rush University Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  MRI Is Superior to Ultrasound of Supraaortic Arteries in Detecting Giant Cell Arteritis - Experience of a Single Center
  

  Abstract Poster Presenter: Marc Schmalzing, MD – University Hospital Wuerzburg
• 1:00 PM – 3:00 PM Eastern Time

  Risk for Visual Loss in Patients with Giant Cell Arteritis
  

  Abstract Poster Presenter: Anne Bull Haaversen, MD – Martina Hansens Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Seasonal Variation in the Incidence of GCA in the UK and Ireland
  

  Abstract Poster Presenter: Leah Rooney, BAO – St Vincent's University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Giant Cell Arteritis Relapse Risk – Could the Extent of Vessel Involvement on Temporal and Axillary Arteries Ultrasound Be a Prognostic Marker?
  

  Abstract Poster Presenter: Diogo Esperança Almeida, MD – Hospital de Braga
• 1:00 PM – 3:00 PM Eastern Time

  Classification Criteria and Existing Pre-Test Probability Stratification Tools Perform Poorly in Diagnosing Giant Cell Arteritis
  

  Abstract Poster Presenter: Victor Yang, MBBS – Austin Health